Michael Gelband’s iShares US Medical Devices ETF IHI Stock Holding History

Michael Gelband’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$296	Buy	+6	New	+$305	﹤0.01%	1510
2022 Q4	–	Sell	-36,030	Closed	-$1.7M	–	1848
2022 Q3	$1.7M	Buy	36,030 +33,545	+1,350%	+$1.74M	0.02%	877
2022 Q2	$125K	Sell	2,485 -27,856	-92%	-$1.52M	﹤0.01%	1723
2022 Q1	$1.85M	Sell	30,341 -34,181	-53%	-$2.04M	0.02%	815
2021 Q4	$4.25M	Buy	+64,522	New	+$4.13M	0.04%	496
2021 Q3	–	Sell	-31,164	Closed	-$1.88M	–	2355
2021 Q2	$1.88M	Buy	+31,164	New	+$1.8M	0.02%	722

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Michael Gelband's IHI Position: Q2 2026 in Review

Michael Gelband opened a new position in iShares US Medical Devices ETF (IHI) in Q2 2026: 6 shares worth $296. The stake represents ﹤0.01% of the portfolio and ranks #1510 among its holdings. This is a return to the name: Michael Gelband previously reported a position in IHI as recently as Q3 2022.

Michael Gelband first reported a position in IHI in Q2 2021 and has held it in 6 quarters since. The position peaked at $4.25M in Q4 2021. 500 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

Michael Gelband held 6 shares of iShares US Medical Devices ETF worth $296 as of Q2 2026.
iShares US Medical Devices ETF was a new Michael Gelband position in Q2 2026.
iShares US Medical Devices ETF made up ﹤0.01% of Michael Gelband's portfolio in Q2 2026, its #1510 holding.
Michael Gelband first reported a position in iShares US Medical Devices ETF in Q2 2021 and has held it in 6 quarters since.
Michael Gelband's iShares US Medical Devices ETF position peaked at $4.25M in Q4 2021.
500 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.